{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:17:35Z","timestamp":1792113455545,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,12,24]],"date-time":"2006-12-24T00:00:00Z","timestamp":1166918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1038\/nchembio850","type":"journal-article","created":{"date-parts":[[2006,12,24]],"date-time":"2006-12-24T16:51:30Z","timestamp":1166979090000},"page":"101-107","source":"Crossref","is-referenced-by-count":228,"title":["Structure of acid \u03b2-glucosidase with pharmacological chaperone provides insight into Gaucher disease"],"prefix":"10.1038","volume":"3","author":[{"given":"Raquel L","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon A","family":"Wustman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Huertas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Allan C","family":"Powe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey W","family":"Pine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richie","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Schlossmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Ringe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A","family":"Petsko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,24]]},"reference":[{"key":"BFnchembio850_CR1","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","volume":"63","author":"AR Sawkar","year":"2006","unstructured":"Sawkar, A.R., D'Haeze, W. & Kelly, J.W. Therapeutic strategies to ameliorate lysosomal storage disorders\u2013a focus on Gaucher disease. Cell. Mol. Life Sci. 63, 1179\u20131192 (2006).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnchembio850_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","volume":"24","author":"JQ Fan","year":"2003","unstructured":"Fan, J.Q. A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity. Trends Pharmacol. Sci. 24, 355\u2013360 (2003).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnchembio850_CR3","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","volume":"269","author":"ME Grace","year":"1994","unstructured":"Grace, M.E., Newman, K.M., Scheinker, V., Berg-Fussman, A. & Grabowski, G.A. Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. J. Biol. Chem. 269, 2283\u20132291 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio850_CR4","doi-asserted-by":"publisher","first-page":"43R","DOI":"10.1093\/glycob\/cwi076","volume":"15","author":"TD Butters","year":"2005","unstructured":"Butters, T.D., Dwek, R.A. & Platt, F.M. Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 15, 43R\u201352R (2005).","journal-title":"Glycobiology"},{"key":"BFnchembio850_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6","volume":"8","author":"E Beutler","year":"1996","unstructured":"Beutler, E. & Gelbart, T. Glucocerebrosidase (Gaucher disease). Hum. Mutat. 8, 207\u2013213 (1996).","journal-title":"Hum. Mutat."},{"key":"BFnchembio850_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","volume":"82","author":"K Wong","year":"2004","unstructured":"Wong, K. et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol. Genet. Metab. 82, 192\u2013207 (2004).","journal-title":"Mol. Genet. Metab."},{"key":"BFnchembio850_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","volume":"67","author":"O Goker-Alpan","year":"2006","unstructured":"Goker-Alpan, O. et al. Glucocerebrosidase mutations are an important risk factor for Lewy body disorders. Neurology 67, 908\u2013910 (2006).","journal-title":"Neurology"},{"key":"BFnchembio850_CR8","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1074\/jbc.M511110200","volume":"281","author":"B Liou","year":"2006","unstructured":"Liou, B. et al. Analyses of variant acid beta -glucosidases: effects of gaucher disease mutations. J. Biol. Chem. 281, 4242\u20134253 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio850_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","volume":"27","author":"D Elstein","year":"2004","unstructured":"Elstein, D. et al. Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. J. Inherit. Metab. Dis. 27, 757\u2013766 (2004).","journal-title":"J. Inherit. Metab. Dis."},{"key":"BFnchembio850_CR10","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.clinthera.2005.08.004","volume":"27","author":"GM Pastores","year":"2005","unstructured":"Pastores, G.M., Barnett, N.L. & Kolodny, E.H. An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatment. Clin. Ther. 27, 1215\u20131227 (2005).","journal-title":"Clin. Ther."},{"key":"BFnchembio850_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1600-0854.2004.00232.x","volume":"5","author":"A Ulloa-Aguirre","year":"2004","unstructured":"Ulloa-Aguirre, A., Janovick, J.A., Brothers, S.P. & Conn, P.M. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease. Traffic 5, 821\u2013837 (2004).","journal-title":"Traffic"},{"key":"BFnchembio850_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","volume":"35","author":"P Alfonso","year":"2005","unstructured":"Alfonso, P. et al. Miglustat (NB-DNJ) works as a chaperone for mutated acid beta-glucosidase in cells transfected with several Gaucher disease mutations. Blood Cells Mol. Dis. 35, 268\u2013276 (2005).","journal-title":"Blood Cells Mol. Dis."},{"key":"BFnchembio850_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbadis.2004.03.007","volume":"1689","author":"H Lin","year":"2004","unstructured":"Lin, H. et al. N-octyl-beta-valienamine up-regulates activity of F213I mutant beta-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease. Biochim. Biophys. Acta 1689, 219\u2013228 (2004).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio850_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/bj20030348","volume":"374","author":"HR Mellor","year":"2003","unstructured":"Mellor, H.R., Platt, F.M., Dwek, R.A. & Butters, T.D. Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation. Biochem. J. 374, 307\u2013314 (2003).","journal-title":"Biochem. J."},{"key":"BFnchembio850_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/cbic.200390045","volume":"4","author":"T Kolter","year":"2003","unstructured":"Kolter, T. & Wendeler, M. Chemical chaperones\u2013a new concept in drug research. ChemBioChem 4, 260\u2013264 (2003).","journal-title":"ChemBioChem"},{"key":"BFnchembio850_CR16","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1073\/pnas.0605928103","volume":"103","author":"RA Steet","year":"2006","unstructured":"Steet, R.A. et al. The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms. Proc. Natl. Acad. Sci. USA 103, 13813\u201313818 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnchembio850_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/sj.embor.embor873","volume":"4","author":"H Dvir","year":"2003","unstructured":"Dvir, H. et al. X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease. EMBO Rep. 4, 704\u2013709 (2003).","journal-title":"EMBO Rep."},{"key":"BFnchembio850_CR18","doi-asserted-by":"publisher","first-page":"23815","DOI":"10.1074\/jbc.M502799200","volume":"280","author":"L Premkumar","year":"2005","unstructured":"Premkumar, L. et al. X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. J. Biol. Chem. 280, 23815\u201323819 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio850_CR19","doi-asserted-by":"crossref","first-page":"10975","DOI":"10.1016\/S0021-9258(19)78077-6","volume":"269","author":"S Miao","year":"1994","unstructured":"Miao, S. et al. Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry. J. Biol. Chem. 269, 10975\u201310978 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnchembio850_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/BJ20050325","volume":"390","author":"R Salvioli","year":"2005","unstructured":"Salvioli, R. et al. The N370S (Asn370 \u2192 Ser) mutation affects the capacity of glucosylceramidase to interact with anionic phospholipid-containing membranes and saposin C. Biochem. J. 390, 95\u2013103 (2005).","journal-title":"Biochem. J."},{"key":"BFnchembio850_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0167-4838(87)90128-2","volume":"915","author":"K Osiecki-Newman","year":"1987","unstructured":"Osiecki-Newman, K., Fabbro, D., Legler, G., Desnick, R.J. & Grabowski, G.A. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites. Biochim. Biophys. Acta 915, 87\u2013100 (1987).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio850_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/0005-2760(81)90134-X","volume":"664","author":"SL Berent","year":"1981","unstructured":"Berent, S.L. & Radin, N.S. Mechanism of activation of glucocerebrosidase by co-beta-glucosidase (glucosidase activator protein). Biochim. Biophys. Acta 664, 572\u2013582 (1981).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnchembio850_CR23","doi-asserted-by":"publisher","first-page":"11544","DOI":"10.1021\/bi980785+","volume":"37","author":"X Qi","year":"1998","unstructured":"Qi, X. & Grabowski, G.A. Acid beta-glucosidase: intrinsic fluorescence and conformational changes induced by phospholipids and saposin C. Biochemistry 37, 11544\u201311554 (1998).","journal-title":"Biochemistry"},{"key":"BFnchembio850_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997).","journal-title":"Methods Enzymol."},{"key":"BFnchembio850_CR25","doi-asserted-by":"crossref","unstructured":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760\u2013763 (1994).","DOI":"10.1107\/S0907444994003112"},{"key":"BFnchembio850_CR26","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnchembio850_CR27","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1107\/S0907444904011679","volume":"60","author":"AW Schuttelkopf","year":"2004","unstructured":"Schuttelkopf, A.W. & vanAalten, D.M. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 60, 1355\u20131363 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnchembio850_CR28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1107\/S0907444904012995","volume":"60","author":"PH Zwart","year":"2004","unstructured":"Zwart, P.H., Langer, G.G. & Lamzin, V.S. Modelling bound ligands in protein crystal structures. Acta Crystallogr. D Biol. Crystallogr. 60, 2230\u20132239 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnchembio850_CR29","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1107\/S0907444904026460","volume":"60","author":"E Krissinel","year":"2004","unstructured":"Krissinel, E. & Henrick, K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60, 2256\u20132268 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFnchembio850_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<407::AID-PATH377>3.0.CO;2-Z","volume":"188","author":"KP Zimmer","year":"1999","unstructured":"Zimmer, K.P. et al. Intracellular transport of acid beta-glucosidase and lysosome-associated membrane proteins is affected in Gaucher's disease (G202R mutation). J. Pathol. 188, 407\u2013414 (1999).","journal-title":"J. Pathol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nchembio850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio850","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nchembio850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T16:00:16Z","timestamp":1684425616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nchembio850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,24]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["BFnchembio850"],"URL":"https:\/\/doi.org\/10.1038\/nchembio850","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1088201.541217","asserted-by":"object"}]},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,24]]}}}